These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34544437)

  • 1. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.
    Luo F; Zeng KM; Cao JX; Zhou T; Lin SX; Ma WJ; Yang YP; Zhang ZH; Lu FT; Huang Y; Zhao HY; Zhang L
    Lipids Health Dis; 2021 Sep; 20(1):109. PubMed ID: 34544437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
    Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
    Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.
    Wang Y; Wang ZQ; Wang FH; Lei XF; Yan SM; Wang DS; Zhang F; Xu RH; Wang LY; Li YH
    Oncotarget; 2016 Aug; 7(35):57290-57300. PubMed ID: 27344180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
    Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
    Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
    Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
    PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
    Tang M; Song C; Zhang Y; Xu X; Wang C; Zhang Z; Chen T
    Lipids Health Dis; 2021 Nov; 20(1):165. PubMed ID: 34801029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
    Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
    BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of preoperative serum triglyceride, high-density lipoprotein, and low-density lipoprotein levels in lung squamous cell carcinoma.
    Li Z; Xu J; Feng W; Ma Z; Wu Y; Zhu T; Xu P; Dong L; Ding J; Zhou J; Yu G
    Sci Rep; 2022 Oct; 12(1):16828. PubMed ID: 36207435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.
    Soran H; France MW; Kwok S; Dissanayake S; Charlton-Menys V; Younis NN; Durrington PN
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):566-71. PubMed ID: 22006975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.
    Ma C; Wang X; Guo J; Liu P
    Lipids Health Dis; 2021 Oct; 20(1):69. PubMed ID: 34598703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer.
    Lin Q; Liu W; Xu S; Sun L
    Arch Gynecol Obstet; 2022 Mar; 305(3):683-691. PubMed ID: 34453586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
    Wen M; Wang L; Wang X; Yang S; Sun Y; Xia J; Zhang Y; Zhang Z; Huang L; Jiang T
    Oncol Res Treat; 2020; 43(12):686-693. PubMed ID: 33197924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
    Yan S; Shun-Chang J; Li C; Jie L; Ya-Li L; Ling-Xiong W
    BMC Cancer; 2010 Nov; 10():621. PubMed ID: 21067592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High BMI and low HDL-C predict the chemotherapy-related hepatic dysfunction in Chinese advanced NSCLC patients.
    Lv Y; Ding XS; Li Y; An X; Miao LY
    Cancer Biomark; 2016; 16(1):89-97. PubMed ID: 26835709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism.
    Zabłocka-Słowińska K; Płaczkowska S; Skórska K; Prescha A; Pawełczyk K; Porębska I; Kosacka M; Grajeta H
    PLoS One; 2019; 14(4):e0215246. PubMed ID: 30973911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.
    Li J; Ma C; Yuan X; Wang X; Li N; Yu R; Liao H
    Curr Oncol; 2022 Aug; 29(9):6125-6136. PubMed ID: 36135050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.